Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis

May-18

AUTHORS : Prof Neil Thomas, PhD, Institute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK – Email: g.n.thomas@bham.ac.uk – Profile: https://www.birmingham.ac.uk/staff/profiles/applied-health/thomas-neil.aspx OR Dr Parth Narendran, Institute of Immunology and Immunotherapy, Research College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK – Email: p.narendran@bham.ac.ukProfile: https://www.birmingham.ac.uk/staff/profiles/immunology-immunotherapy/narendran-parth.aspx (Dr Narendram named in top experts in Type 1 Diabetes: https://www.birmingham.ac.uk/university/colleges/mds/news/2019/03/parth-award.aspx)

JOURNAL : Diabetologia

REFERENCE: 61(5):1064-1070

DOI : 10.1007/s00125-018-4574-6

Clinically meaningful and lasting HbA1c improvement rarely occurs after 5 years of type 1 diabetes: an argument for early, targeted and aggressive intervention following diagnosis

More publications

Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis

Using repeated measurements to predict cardiovascular risk in patients with type 2 diabetes Mellitus

Inequalities in the management of diabetic kidney disease in UK primary care: A cross-sectional analysis of a large primary care database